BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28524711)

  • 1. The will to live - breast cancer patients perceptions' of palliative chemotherapy.
    Bergqvist J; Strang P
    Acta Oncol; 2017 Sep; 56(9):1168-1174. PubMed ID: 28524711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Patients' Preferences for Truth Versus Hope Are Dynamic and Change During Late Lines of Palliative Chemotherapy.
    Bergqvist J; Strang P
    J Pain Symptom Manage; 2019 Apr; 57(4):746-752. PubMed ID: 30639732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy.
    Pujol JL; Roch B; Roth C; Mérel JP
    PLoS One; 2018; 13(5):e0197605. PubMed ID: 29799879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy.
    Grunfeld EA; Maher EJ; Browne S; Ward P; Young T; Vivat B; Walker G; Wilson C; Potts HW; Westcombe AM; Richards MA; Ramirez AJ
    J Clin Oncol; 2006 Mar; 24(7):1090-8. PubMed ID: 16505428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
    Jansen SJ; Otten W; Stiggelbout AM
    Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preference weights for chemotherapy side effects from the perspective of women with breast cancer.
    Kuchuk I; Bouganim N; Beusterien K; Grinspan J; Vandermeer L; Gertler S; Dent SF; Song X; Segal R; Mazzarello S; Crawley F; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2013 Nov; 142(1):101-7. PubMed ID: 24129976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic palliative approaches in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):2-9. PubMed ID: 7537899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
    Geels P; Eisenhauer E; Bezjak A; Zee B; Day A
    J Clin Oncol; 2000 Jun; 18(12):2395-405. PubMed ID: 10856099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
    Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
    Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personal control over the cure of breast cancer: adaptiveness, underlying beliefs and correlates.
    Henselmans I; Sanderman R; Helgeson VS; de Vries J; Smink A; Ranchor AV
    Psychooncology; 2010 May; 19(5):525-34. PubMed ID: 19557825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
    Partridge AH; Sepucha K; O'Neill A; Miller KD; Motley C; Swaby RF; Schneider BP; Dang CT; Northfelt DW; Sledge GW
    JAMA Oncol; 2015 Jun; 1(3):369-74. PubMed ID: 26114161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
    Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
    Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for managing metastatic breast cancer.
    Olin JJ; Muss HB
    Oncology (Williston Park); 2000 May; 14(5):629-41; discussion 642-4, 647-8. PubMed ID: 10853456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom management tasks and behaviors related to chemotherapy in Taiwanese outpatients with breast cancer.
    Kuo CY; Liang SY; Tsay SL; Wang TJ; Cheng SF
    Eur J Oncol Nurs; 2015 Dec; 19(6):654-9. PubMed ID: 25959612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.
    Doyle C; Crump M; Pintilie M; Oza AM
    J Clin Oncol; 2001 Mar; 19(5):1266-74. PubMed ID: 11230467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention.
    Kreling B; Figueiredo MI; Sheppard VL; Mandelblatt JS
    Psychooncology; 2006 Dec; 15(12):1065-76. PubMed ID: 16598833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
    Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y
    Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informational needs of breast cancer patients on chemotherapy: differences between patients' and nurses' perceptions.
    Lei CP; Har YC; Abdullah KL
    Asian Pac J Cancer Prev; 2011; 12(3):797-802. PubMed ID: 21627386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.